Testing effectiveness (Phase 2)Study completedNCT03044626
What this trial is testing
Fostering Efficacy of Anti - PD-1 - Treatment: Nivolumab Plus Radiotherapy in Advanced NSCLC
Who this might be right for
Carcinoma,Non-Small-Cell LungMetastatic Lung CancerNonsmall Cell Lung Cancer+2 more
AIO-Studien-gGmbH 101